Eczema treatment in Kollam,
IADVL atopic-dermatitis consensus, dupilumab where indicated.

Eczema is a chronic condition with a genetic component and there is no permanent cure with current medicine. However, modern treatments including dupilumab biologics and structured barrier repair achieve sustained remission in most patients. The realistic goal is long-term control with minimal flares. Our dermatologists at DermaVue Kollam design maintenance protocols that keep symptoms suppressed.

Published research in Clinical and Experimental Allergy 2021 and the UK Biobank study 2023 confirms hard water exposure increases eczema risk and flare frequency. Kollam coastal groundwater reaches TDS levels of 2,250 mg per litre, over four times the WHO guideline. Our dermatologists recommend specific chelating rinses and post-wash barrier repair protocols for affected patients.

Monsoon in Kollam from June to October brings 80 percent humidity, which triggers sweat-induced irritation on barrier-compromised skin. Secondary fungal colonisation of eczematous patches is also common in this period. Pre-monsoon dermatologist review and adjusted therapy reduce monsoon flares significantly.

Yes. DermaVue Kollam prescribes and monitors dupilumab, an IL-4 and IL-13 inhibitor that the AAD 2025 guidelines strongly recommend for moderate-to-severe atopic dermatitis. FDA-approved for patients aged 6 months and older, dupilumab requires no routine blood monitoring. Most patients notice reduced itch within 2 to 4 weeks and progressive skin clearing over 16 weeks.

Cashew nut shell liquid contains anacardic acid, a potent irritant that cross-reacts with poison ivy. A 2024 study in the Indian Journal of Occupational and Environmental Medicine found dermatological problems in 47.5 percent of cashew processing workers surveyed. The presentation of chronic hand dermatitis with fissuring requires patch testing to distinguish from atopic eczema. DermaVue Kollam offers comprehensive allergen testing and occupational skin management.

Consultation at DermaVue Kollam is Rs.300. Mild eczema managed with topical therapy costs Rs.500 to Rs.1,500 per month for medications. Phototherapy sessions are priced per session with packages available. Dupilumab for severe cases is a significant investment and your dermatologist discusses all options including insurance documentation.

Eczema involves barrier dysfunction and typically causes intense itch with dry, cracked, weeping patches in flexural areas. Psoriasis is an autoimmune condition producing thick, silvery-scaled plaques on extensor surfaces. The treatments differ substantially. Accurate diagnosis by a board-certified dermatologist is essential because the wrong treatment worsens either condition.

No. Topical corticosteroids remain the most effective first-line treatment for eczema flares when used correctly. The problem is unsupervised prolonged daily use, which causes skin thinning and steroid dependence. A dermatologist prescribes the right potency for each body area, sets clear duration limits, and rotates with steroid-sparing agents like tacrolimus for maintenance.

DermaVue Kollam at Kavanad is approximately 10 minutes from Chinnakada and staffed by board-certified MD DVL dermatologists who specialise in eczema management including severity scoring, patch testing and biologic therapy. The clinic is part of a dermatologist-owned 7-clinic network rated 4.9 stars with 370+ Google reviews.

Yes, with dermatologist guidance. Mild topical steroids and calcineurin inhibitors such as pimecrolimus and tacrolimus are safe for paediatric use in appropriate concentrations. Dupilumab is FDA-approved for children as young as 6 months for moderate-to-severe atopic dermatitis. A paediatric eczema consultation at DermaVue assesses severity, identifies triggers and builds an age-appropriate treatment plan.